SARS-CoV-2

Category

Cleveland Research Centers Receive $2.6m & Participate in NCI’s ‘SeroNet’ Study of Human Immune Responses to COVID-19

The National Cancer Institute (NCI) injected $2.6 million into research involving two studies led by Case Western Reserve University and Cleveland Clinic as part of the NCI’s Serological Sciences Network (SeroNet), which recently awarded 13 grants nationwide. This...

Canadian Centre for Vaccinology Receives Federal Grant for Certification to Directly Handle SARS-CoV-2

Earlier on during the pandemic, Halifax-based Canadian Centre for Vaccinology, associated with Dalhousie University, was front and center in the war against COVID-19 in Canada, preparing for major vaccine research in conjunction with CanSino Biologics. That deal fell...

RLF-100 Expanded Access Program At Houston Methodist Hospital 9-Fold Increased Probability of Survival from Critical COVID-19

Patients with critical COVID-19 and respiratory failure treated with RLF-100™ (aviptadil) have a 9-fold increased probability of survival and recovery from respiratory failure than those patients only on the standard of care, reports Relief Therapeutics Holding AG...

Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis: Drug Effective Against COVID-19

A principal investor from Zagazig University, Dr. Waheed Shouman, recently completed a randomized, open label, interventional trial titled “Use of Ivermectin as Prophylactic Option in Asymptomatic Family Close Contact for Patient with COVID-19.” Targeting 340...

Remdesivir Use in Multi-National Clinical Trial of Patients with Moderate COVID-19 & Pneumonia: Perplexing Results

Remdesivir is the only therapy in the United States approved, under emergency use status, as a treatment for COVID-19 along with the just announced convalescent plasma. Referred to as not a ‘knockout drug’ by Dr. Anthony Fauci, Director of the National Institutes of...

Pin It on Pinterest